Women who develop breast tenderness after starting combination estrogen and progestin menopause therapy have a 33 percent higher risk of developing breast cancer than those who don’t experience breast tenderness, a new study says. It also found that new-onset breast tenderness was not associated with increased breast cancer risk among women taking estrogen alone.
